HPLC purity assay Mass-spec identity Measured content 48.74mg Test date 28/05/2026 Current batch NVCU50-01052026 Method HPLC LC-MS Certificate of Analysis available Download or independently verify the full third-party report for this peptide
CJC-1295 (No DAC) + Ipamorelin Blend 10mg Research-grade CJC-1295 (No DAC) + Ipamorelin Blend, a dual-pathway growth hormone research complex combining Modified GRF (1-29) (5mg) and Ipamorelin (5mg)
4 Oxidative stress is implicated in the pathogenesis of various diseases, including viral infections and inflammatory conditions
Pharmacokinetic characterisation is comparatively thin, but distribution and elimination have been profiled in rats and dogs in a 2023 pharmacokinetic study (PMC9794587), which is useful context because most claims about systemic healing rest on animal exposure data rather than validated human pharmacology
Long-term or unsupervised use is not recommended, as excessive dosing may lead to unknown health effects
(PubMed) Rude RK, Shils ME